![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 49, 47313-47317, December 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
**,
**
, and
**§§
From the
Cell Regulation and Signalling Group, School
of Biological Sciences, University of Liverpool, Liverpool L69 7ZB,
United Kingdom and the ¶ Division of Cell Signalling, School of
Life Sciences, The University of Dundee, Dundee DD1 5EH, United
Kingdom
Received for publication, September 24, 2002
| |
ABSTRACT |
|---|
|
|
|---|
A total of 17 Nudix hydrolases were tested for
their ability to hydrolyze 5-phosphoribosyl 1-pyrophosphate (PRPP). All
11 enzymes that were active toward dinucleoside polyphosphates with 4 or more phosphate groups as substrates were also able to hydrolyze PRPP, whereas the 6 that could not and that have coenzyme A,
NDP-sugars, or pyridine nucleotides as preferred substrates did not
degrade PRPP. The products of hydrolysis were ribose 1,5-bisphosphate and Pi. Active PRPP pyrophosphatases included the
diphosphoinositol polyphosphate phosphohydrolase (DIPP) subfamily of
Nudix hydrolases, which also degrade the non-nucleotide
diphosphoinositol polyphosphates. Km and
kcat values for PRPP hydrolysis for the
Deinococcus radiodurans DR2356 (di)nucleoside polyphosphate
hydrolase, the human diadenosine tetraphosphate hydrolase, and human
DIPP-1 (diadenosine hexaphosphate and diphosphoinositol polyphosphate
hydrolase) were 1 mM and 1.5 s The Nudix hydrolases are members of an enzyme family that
was named after their ability to hydrolyze predominantly the
pyrophosphate linkage in a variety of compounds having the general
structure of a nucleoside diphosphate (Npp) linked to another moiety,
X, with varying degrees of specificity (1, 2). Thus,
nucleoside triphosphates (Npp-p), dinucleoside polyphosphates
(Npp-pnN), nucleotide sugars (Npp-sugar), NADH, and
coenzyme A are examples of Nudix hydrolase substrates that fall into
this category. In general terms, the members of this protein family are
believed to rid the cell of potentially deleterious endogenous
nucleotide metabolites and to modulate the accumulation of metabolic
intermediates by diverting them into alternative pathways in response
to biochemical need, although specific regulatory functions may also be
associated with individual members (1).
Recently, a subfamily of Nudix hydrolases has been described that
hydrolyze the long chain dinucleoside and nucleoside polyphosphates, including diadenosine
5',5 The ability of this subset of Nudix hydrolases to utilize a sugar
pyrophosphate as a substrate prompted us to test another such compound
of known biological importance, 5-phosphoribosyl 1-pyrophosphate
(PRPP). PRPP is both a substrate and regulator of purine, pyrimidine,
and pyridine nucleotide synthesis (18-21); in bacteria and lower
eukaryotes it is also a precursor for histidine and tryptophan
biosynthesis (22-25). Furthermore, a potential product of
pyrophosphatase activity acting upon PRPP is ribose 1,5-bisphosphate (Rib-1,5-P2), which has recently been shown to be a
physiological regulator of glycolysis and the fructose
6-phosphate/fructose 1,6-bisphosphate cycle (26-28). Here, we show
that Nudix hydrolases of the DIPP subfamily and the related
Ap4A hydrolases all exhibit PRPP pyrophosphatase activity,
whereas Nudix hydrolases previously shown to be specific for
NDP-sugars, pyridine nucleotides, and coenzyme A are unable to
hydrolyze PRPP.
Materials--
Recombinant human Aps1 (DIPP-3 Assay of PRPP Pyrophosphatase Activity--
Initial screening of
enzyme preparations for their ability to release Pi from
PRPP was carried out using a phosphomolybdate colorimetric assay (33).
Purified enzymes (5 µg) were incubated for 15 min at 37 °C in 50 mM Tris-HCl, pH 8.0, 5 mM Mg acetate, 1 mM dithiothreitol, and 0.2 mM PRPP in a total
volume of 200 µl and the reactions stopped by the addition of the
molybdate detection reagent. Enzymes testing negative in an initial
screen were retested with up to 12 µg of protein per assay. Kinetic
constants for PRPP hydrolysis by selected enzymes were calculated from
initial rates determined using a sensitive continuous
spectrophotometric assay based on the phosphate-dependent
conversion of 2-amino-6-mercapto-7-methylpurine riboside to
2-amino-6-mercapto-7-methylpurine and ribose-1-phosphate catalyzed by
purine nucleoside phosphorylase (34). For this, the EnzChek® assay
kit was used according to the manufacturer's instructions with the
following modifications: reactions were preincubated for 5 min without
substrate at 37 °C in 50 mM BisTrisPropane buffer, pH
8.5, 5 mM Mg acetate, and 1 mM dithiothreitol
and then incubated with substrate for up to 2 min. Final enzyme
concentrations were 75 µg/ml (human Ap4A hydrolase), 15.2 µg/ml (DIPP-1), and 7 µg/ml (D. radiodurans
ApnA hydrolase). In each case, controls lacking substrate
or enzyme were performed.
HPLC Analysis of PRPP Hydrolysis Products--
The products of
PRPP hydrolysis by the D. radiodurans ApnA
hydrolase were generated by incubation of 0.2 mM PRPP with
7 µg of enzyme in 50 mM Tris-HCl, pH 8.0, 5 mM Mg acetate, 1 mM dithiothreitol for 10 min
at 37 °C. Reactions (200 µl) were stopped by freezing and then
applied to a 1-ml Resource-Q column (Pharmacia) at 2 ml/min in 35 mM NH4HCO3, pH 9.6. The elution
system consisted of a gradient of 5-100% buffer A (0.7 M
NH4HCO3, pH 9.6) in water over 10 min.
Fractions (0.5 ml) were collected and the presence of products
determined by colorimetric determination of phosphate released after
incubation with alkaline phosphatase or inorganic pyrophosphatase as
required (33, 35).
Other Methods--
Ap4A hydrolase activity was
determined luminometrically as previously described (3). Protein
concentrations were estimated by the Coomassie Blue binding method
(36). Positive ion electrospray mass spectrometry was performed as
previously described (11).
Hydrolysis of PRPP by Nudix Hydrolases--
A total of 17 different Nudix hydrolases were tested for their ability to hydrolyze
PRPP. The assay employed measures the release of inorganic phosphate.
As can be seen from Table I, all 11 enzymes that can utilize dinucleoside polyphosphates with 4 or more
phosphate groups as substrates are also able to hydrolyze PRPP, whereas
the 6 that cannot and that have coenzyme A, NDP-sugars, or pyridine
nucleotides as preferred substrates do not degrade PRPP. It should be
stressed that the rates quoted of micromoles of Pi produced
min
Km and kcat values for PRPP
were determined for one prokaryotic ApnA hydrolase, one
eukaryotic Ap4A hydrolase, and one eukaryotic
Ap6A hydrolase/DIPP, using a continuous spectrophotometric assay. D. radiodurans DR2356 ApnA hydrolase is
an enzyme that hydrolyzes a variety of nucleoside and dinucleoside
polyphosphates, including p4A, p5A,
Ap4A, Ap5A, and Ap6A.5
It has no activity toward diphosphoinositol
polyphosphates4; however, it readily hydrolyzes PRPP with a
Km of 1 mM and a
kcat of 1.5 s Identification of Rib-1,5-P2 as the Product of PRPP
Hydrolysis--
Because all Nudix hydrolases cleave pyrophosphate
linkages, it was anticipated that they would remove the The results reported here are important for two reasons. First,
they have implications for the specificity and physiological function(s) of Nudix hydrolases, particularly the DIPP/ApnA
hydrolases, and secondly, they impact on the metabolism of PRPP and the
generation from it of the regulatory molecule Rib-1,5-P2.
Regarding the enzymes themselves, the surprising ability of the active
sites of the DIPPs to accommodate two seemingly unrelated sets of
substrates, the diadenosine and diphosphoinositol polyphosphates, has
already been highlighted (5). The use of PRPP as a substrate by these enzymes makes this easier to understand. Modeling of PRPP onto the
crystal structure of the C. elegans Ap4A
hydrolase (39) shows that it can fit readily into the substrate-binding
cleft with its 5-phosphate located in the exact position occupied by the P1 phosphate of Ap4A and the
1, 0.13 mM and 0.057 s
1, and 0.38 mM and
1.0 s
1, respectively. Active site mutants of the
Caenorhabditis elegans diadenosine tetraphosphate hydrolase
had no activity, confirming that the same active site is responsible
for nucleotide and PRPP hydrolysis. Comparison of the specificity
constants for nucleotide, diphosphoinositol polyphosphate, and PRPP
hydrolysis suggests that PRPP is a significant substrate for the
D. radiodurans DR2356 enzyme and for the DIPP
subfamily. In the latter case, generation of the glycolytic
activator ribose 1,5-bisphosphate may be a new function for these enzymes.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-P1,P6-hexaphosphate
(Ap6A),1
diadenosine
5',5
-P1,P5-pentaphosphate
(Ap5A), and adenosine 5'-pentaphosphate (p5A) but which have relatively low activity with diadenosine
5',5
-P1,P4-tetraphosphate
(Ap4A). Most interestingly, these enzymes also act as
phosphohydrolases toward the non-nucleotide substrates, diphosphoinositol pentakisphosphate (PP-InsP5) and
bisdiphosphoinositol tetrakisphosphate
([PP]2-InsP4), with varying degrees of
efficiency relative to the nucleotide substrates. Structurally and
mechanistically, they are closely related within the Nudix family to
the well studied Ap4A hydrolases (3, 4), although the
latter enzymes do not appear to utilize PP-InsP5 or
[PP]2-InsP4 as substrates (5). So far, four
distinct genes (excluding pseudogenes) and five distinct gene products
in this Ap6A hydrolase/diphosphoinositol polyphosphate phosphohydrolase (DIPP) subfamily have been described in mammalian cells, DIPP-1 (NUDT3) (6), DIPP-2
and -2
(NUDT4) (7, 8), DIPP-3
(NUDT10, hAps2), and
-3
(NUDT11, hAps1) (9, 10), whereas the yeasts
Saccharomyces cerevisiae (DDP1) (5, 11) and
Schizosaccharomyces pombe (Aps1) (5, 12) appear
to have one each. PP-InsP5 and
[PP]2-InsP4 are also substrates for
the g5R Nudix hydrolase encoded by African Swine Fever virus (13). Several of these enzymes have high affinities and high
kcat/Km ratios for the
diphosphoinositol polyphosphates, suggesting that these compounds may
be important substrates in vivo. They may be involved in the
regulation of vesicle trafficking (14), apoptosis (15), DNA repair
(16), and in vacuole biogenesis and environmental stress responses in
yeast (17); hence, the DIPP Nudix hydrolases have also been implicated
in these processes.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
) and Aps2
(DIPP-3
) (10), S. cerevisiae Ddp1p Ap6A
hydrolase (YOR163w protein) (11), and Npy1p NADH pyrophosphatase
(YGL067w protein) (29), Caenorhabditis elegans
Ap4A hydrolase (3), African Swine Fever virus g5R protein (13), human NUDT5 ADP-sugar hydrolase (30), NUDT9 ADP-ribose hydrolase
(31), and mouse Nudt7 coenzyme A pyrophosphatase (32) were
prepared as previously described. Active site mutants of the C. elegans Ap4A hydrolase (E52Q and E56Q) were a gift
from H. Abdelghany.2 The YgdP
Ap4A hydrolase from Salmonella typhimurium was a
gift from T. Ismail.3
Recombinant human DIPP-1, DIPP-2
, and -2
were prepared as
GST-fusion proteins as described for hAps1 and
hAps24 (10). Recombinant
human Ap4A hydrolase, Deinococcus radiodurans coenzyme A pyrophosphatase (DR1184 gene product), and D. radiodurans ApnA hydrolase (DR2356 gene product) were
prepared by procedures similar to those used for the C. elegans Ap4A
hydrolase.5 PRPP and all
nucleotides were from Sigma. The EnzChek® phosphate assay kit was
from Molecular Probes.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1·micromoles protein
1 are not directly
convertible to true kcat values because a
standard set of conditions, including a fixed PRPP concentration of 200 µM, was employed for all assays and so is not necessarily
optimal for each enzyme. Therefore, the rank order of PRPP hydrolase
activity should only be taken as a guide. Because PRPP is known to
undergo spontaneous, Mg2+-dependent non-enzymic
hydrolysis (37, 38), it was important to establish that the observed
activity was enzyme-catalyzed. This is clearly demonstrated by the lack
of degradation by two active site mutants of the C. elegans
Ap4A hydrolase (Table I). In common with other Nudix
hydrolases, substitution of Glu residues in the Nudix motif by Gln
dramatically reduced activity of this enzyme toward Ap4A.
Compared with the wild type value of 23 s
1, the C. elegans E52Q and E56Q mutants have kcat
values for Ap4A of 0.0052 and 0.00024 s
1,
respectively.2 They are also completely inactive with PRPP.
This establishes that the same active site is responsible for
Ap4A and PRPP hydrolysis. The same is assumed to hold true
for the other enzymes.
Utilization of PRPP as a substrate by several Nudix hydrolases
1 (Table
II). For comparison,
Km and kcat values for
Ap4A were determined to be 30 µM and 0.035 s
1, respectively, resulting in similar specificity
constants (kcat /Km) for both
substrates (Table II). Human Ap4A hydrolase also hydrolyzed
PRPP with a kcat of 0.057 s
1 and a
Km of 0.13 mM (Table II). In this case,
however, the specificity constant with PRPP was some 20,000-fold lower than that found with Ap4A as substrate. Finally, human
DIPP-1 was the most efficient of the three enzymes at PRPP hydrolysis in vitro with a kcat of 1.0 s
1 and a Km of 0.38 mM
(Table II). The specificity constant with PRPP of 2,600 was 325- and
18,000-fold lower than those previously measured with Ap6A
and PP-InsP5, respectively (5). The physiological significance of these data is discussed below.
Kinetic constants for substrate hydrolysis by selected Nudix hydrolases
-phosphate
from the pyrophosphate moiety attached to the ribose C1. Using the D. radiodurans DR2356 ApnA hydrolase as an
example enzyme, the products of hydrolysis were first separated by
anion-exchange HPLC, fractions collected and incubated with alkaline
phosphatase, and the Pi released determined
colorimetrically. Two products, A and B, were observed that
co-chromatographed with Pi and PPi, respectively (Fig. 1). Peak area
integration showed the ratio of phosphate released from PRPP, B, and A
to be exactly 3:2:1. Because A did not co-chromatograph with
ribose-1-phosphate (Rib-1-P) or ribose 5-phosphate (Rib-5-P) it must be
Pi. Product B could be Rib-1,5-P2, ribosyl
1-pyrophosphate, 5-phosphoribosyl 1,2-(cyclic) phosphate (37, 38),
or, less likely, PPi itself. Therefore, a sample of product
B was subjected to TLC before and after acid treatment. Acid removes
phosphate from the anomeric C1 but not from C5, and ribose and
derivatives with an unesterified C1 hydroxyl can be detected after TLC
by AgNO3 treatment (38). Fig.
2 shows the TLC plate after
AgNO3 treatment. It can clearly be seen that product B was
not detected by AgNO3 before acid treatment because it has
an esterified C1-OH (lane C); however, after acid treatment, product B generated a visible spot that co-chromatographed with Rib-5-P
and acid-treated PRPP (lane F). This indicates that product B must be Rib-1,5-P2. This identification was confirmed by
positive ion electrospray mass spectrometry. B had a mass of 333 Da,
corresponding to the monosodium salt of Rib-1,5-P2 (not
shown). A cyclic phosphate product would have had a mass 17 Da less.
Therefore it can be concluded that the D. radiodurans DR2356
ApnA hydrolase is a PRPP pyrophosphatase producing
Rib-1,5-P2 and Pi from PRPP. The products of
PRPP hydrolysis generated by the human Ap4A hydrolase had
the same HPLC retention times as those produced by the D. radiodurans DR2356 Ap4A hydrolase. Therefore, given
the conserved reaction mechanism employed by all Nudix hydrolases, it
seems highly likely that Rib-1,5-P2 and Pi are
the products in all cases.

View larger version (21K):
[in a new window]
Fig. 1.
Anion-exchange HPLC analysis of the products
of PRPP hydrolysis by the D. radiodurans DR2356
ApnA hydrolase. Samples of PRPP before (
) and after
(
) incubation with 7 µg of D. radiodurans DR2356
ApnA hydrolase were subjected to anion-exchange
chromatography on a Resource-Q column and fractions collected as
described under "Experimental Procedures." The positions of
Rib-1-P, Rib-5-P, PPi, and Pi standards are
indicated by arrows.

View larger version (91K):
[in a new window]
Fig. 2.
TLC analysis of the ribose-containing product
of PRPP hydrolysis by the D. radiodurans DR2356
ApnA hydrolase. A, cellulose TLC plate
(Merck, 0.1 mm) was spotted with five 200-nl aliquots each of 10 mM Rib-1-P (lane A), PRPP (lane B),
ribose (lane D), and Rib-5-P (lane E), and also
samples of the same compounds previously treated for 1 h at
37 °C with 25 mM HCl: PRPP (lane G), Rib-1-P
(lane H), ribose (lane I), and Rib-5-P
(lane J). The peak fraction of product B from Fig. 1 was
freeze-dried, dissolved in 20 µl of H2O; 10 µl of this
was treated with HCl as above. Five 200-nl aliquots of untreated
(lane C) and acid-treated (lane F) product were
applied to the TLC plate. The plate was developed and spots located as
described in Ref. 38.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-phosphate
of the pyrophosphate moiety located where the attacked P4
phosphate of Ap4A lies (Fig.
3). The same water (or hydroxyl) responsible for nucleophilic attack at P4 could attack this
-phosphate. This model is consistent with the requirement for the
catalytic residues Glu52 and Glu56 in the
C. elegans Ap4A hydrolase. The
-phosphate of
the pyrophosphate group can readily occupy the position of the ribose
moiety of the `AMP product' of Ap4A because this is
already known to accommodate the P5 phosphate of
Ap5A and to lie outside the protein structure. The ribose
ring of PRPP occupies the same position as the P2 and
P3 phosphates of Ap4A. The
substrate-binding cleft is wide at this point, and the residue side
chains in this region are either small (Ala5,
Ala25, Thr33, and Gly37) or are
highly mobile and lack electron density in the crystal structure of the
C. elegans hydrolase (Tyr27); therefore, a
variety of structures may be accommodated in this region because it
appears to provide few, if any, phosphate-specific contacts.

View larger version (58K):
[in a new window]
Fig. 3.
A model of PRPP in the substrate-binding site
of the C. elegans Ap4A hydrolase.
PRPP was modeled into the substrate-binding site of the C. elegans Ap4A hydrolase (PDB entry 1KT9) using
Turbo-Frodo software and the PRPP coordinates taken from the ternary
complex of hypoxanthine guanine
phosphoribosyltransferase-PRPP-9-deazaguanuine (PDB entry 1FSG).
The positions of Tyr76 and Tyr121, which bind
one adenine ring between them in the previously described binary
complex, and of Glu52, one of the catalytic Glu residues in
the loop-helix-loop active site motif, are indicated. Phosphoryl groups
of PRPP are shown as 5-P, P
, and P
.
A major determinant of the stability of the C. elegans
Ap4A hydrolase-PRPP complex is probably the binding of the
5-phosphate by salt bridges/H-bonds to His31,
Lys36, Tyr76, and Lys83. These
residues are important for binding the P1 phosphate of
Ap4A (39). Stacking of the adenosine moiety attached to
P1 between the aromatic rings of Tyr76 and
Tyr121 does not seem to be as critical for Ap4A
binding as was predicted from the crystal structure. We have found that
mutation of both Tyr residues to Ala still yields active
Ap4A hydrolase with a 20-fold lower
kcat (1.1 s
1) and only a 4-fold
higher Km (33 µM) for
Ap4A.2 Thus, the binding of the PRPP phosphates
on C5 and C1 as in Ap4A and the accommodation of the ribose
in a relatively nonspecific region of the binding cleft appear to be
sufficient to allow PRPP to behave as a substrate for the C. elegans Ap4A hydrolase. Similar arguments presumably
apply to the other Ap4A hydrolases and DIPPs and to the
ability of the DIPPs to bind diphosphoinositol polyphosphates. This
model also explains why the Nudix hydrolases with specificities for
NADH, NDP-sugars, and coenzyme A do not accept PRPP as a substrate. These enzymes do not have a second phosphate binding site (like P1) located the required distance away from the catalytic
binding site (like P4). Only enzymes able to hydrolyze
nucleotide substrates with four or more phosphates in the polyphosphate
chain should bind PRPP. These results emphasize the point that certain
Nudix hydrolases can also accept non-nucleotide substrates and should
prompt the search for other such substrates that satisfy these minimal
binding requirements.
Is PRPP a physiologically relevant substrate for any of the enzyme studies here? According to the measured specificity constants, at least for the eukaryotic enzymes, the diadenosine and diphosphoinositol polyphosphates appear to be highly favored over PRPP. However, this does not take into account the relative substrate concentrations in vivo. Literature values for the intracellular concentration of PRPP vary considerably and have been reported in different units. However, taking various measurements for prokaryotes (25, 40, 41) and eukaryotes (20, 26, 42-44) and applying the unit conversion factors of Traut (45) suggests that prokaryotes typically have a PRPP steady-state concentration of around 1 mM, whereas in eukaryotes (excluding erythrocytes) it is 1-2 orders of magnitude lower, although it can be as high as 0.4 mM in mouse fibroblasts deficient in adenine and hypoxanthine phosphoribosyltransferases (43, 45). The measured Km values for PRPP for all three enzymes are, therefore, within acceptable ranges if PRPP were to be considered a physiologically relevant substrate. The intracellular concentration of Ap4A in unstressed cells is typically 0.1-1.0 µM (46), whereas PP-InsP5 may be in the low micromolar range (47). There are no measurements of cytoplasmic Ap6A in mammalian cells; an estimate of 32 nM in platelets is an intracellular average because the Ap6A is concentrated in the dense granules (48). Indeed, it is likely to be even lower than the sole measured value for Ap5A of 4 nM in Schizosaccharomyces pombe (52). Taking the product of the specificity constant and substrate concentration as a better indication of potential substrate utilization in vivo shows that PRPP hydrolysis is likely to be a much more significant reaction in vivo for the D. radiodurans ApnA hydrolase than is Ap4A hydrolysis (Table II). In contrast, the human Ap4A hydrolase is more likely to act upon Ap4A than on PRPP. For DIPP-1, PP-InsP5 still appears to be the favored substrate by virtue of its extremely low Km for this compound. Nevertheless, the combined activities of members of the DIPP subfamily could still have a significant impact on PRPP hydrolysis in vivo in tissues where more than one is expressed.
PRPP pyrophosphatase activity in cell extracts has been detected
before. Divalent ion-dependent (49) and -independent (50) activities were ascribed to acid and alkaline phosphatase,
respectively. Like the spontaneous degradation of PRPP, these reactions
are believed to proceed via 1,2 and 1,5 cyclic derivatives to Rib-1-P and -5-P and ultimately to ribose with Rib-1,5-P2 as a
possible minor intermediate in one pathway (37, 38). In view of the established mechanisms of Nudix hydrolases and the fact that
Ap4A hydrolysis is known to proceed by direct in-line
attack of water (51), a cyclic intermediate is unlikely; generation of
Rib-1,5-P2 most probably occurs directly by nucleophilic
attack of water on the C1
-phosphate rather than via a complex route
involving the initial internal attack of a ribose hydroxyl. Recently,
it has been clearly demonstrated (26) that the rapid rise in
Rib-1,5-P2 that occurs in macrophages under hypoxic
conditions in parallel with the switch to anaerobic glycolysis is due
to a rise in PRPP accompanied by the activation of an unidentified PRPP
pyrophosphatase. This activity appears to be divalent ion-independent
and may be activated by protein kinase C. Its possible relationship to
any of the mammalian Nudix PRPP pyrophosphatases described here is unknown. Nevertheless, it is clear that, at least in mammalian cells,
several Nudix hydrolases exist that have the ability to generate
Rib-1,5-P2 from PRPP. Like fructose 2,6-bisphosphate, this
molecule is a potent activator of phosphofructokinase, is also an
inhibitor of fructose 1,6-bisphosphatase, and is believed to be an
important regulator of glycolysis (26-28). The Nudix PRPP pyrophosphatases must be considered potential generators of
Rib-1,5-P2 in vivo and, therefore, regulators of
glucose metabolism. Verification of this possibility will require
measurements of PRPP and Rib-1,5-P2 in cells in which the
relevant Nudix hydrolase activities have been reduced by gene
disruption or knockdown.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. J. B. Rafferty for assistance with the molecular modeling.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Recipient of a studentship from the Biotechnology and Biological Sciences Research Council (BBSRC).
Supported by the Royal Society and Tenovus (Scotland).
** Supported by the BBSRC (Grant 26/PRS11831) and the Wellcome Trust.

To whom correspondence should be addressed: School of
Biological Sciences, University of Liverpool, Life Sciences Bldg.,
Liverpool L69 7ZB, UK. Tel.: 0151-794-4369; Fax: 0151-794-4349; E-mail: agmclen@liv.ac.uk.
§§ Present address: Dept. of Biology, University of York, P.O. Box 373, York YO10 5YW, UK.
Published, JBC Papers in Press, October 4, 2002, DOI 10.1074/jbc.M209795200
2 H. Abdelghany and A. G. McLennan, unpublished data.
3 T. Ismail and A. G. McLennan, unpublished data.
4 S. T. Safrany, unpublished observations.
5 D. I. Fisher, J. L. Cartwright, and A. G. McLennan, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Ap6A, diadenosine
5',5
-P1,P6-hexaphosphate;
Ap4A, diadenosine
5',5
-P1,P4-tetraphosphate;
Ap5A, diadenosine
5',5
-P1,P5-pentaphosphate;
ApnA, diadenosine
5',5
-P1,Pn-polyphosphate;
DIPP, diphosphoinositol polyphosphate phosphohydrolase;
NUDT, Nudix-type gene;
PP-InsP5, diphosphoinositol
pentakisphosphate;
[PP]2-InsP4, bisdiphosphoinositol tetrakisphosphate;
PRPP, 5-phosphoribosyl
1-pyrophosphate;
Rib-1-P, ribose 1-phosphate;
Rib-5-P, ribose
5-phosphate;
Rib-1, 5-P2, ribose 1,5-bisphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bessman, M. J.,
Frick, D. N.,
and O'Handley, S. F.
(1996)
J. Biol. Chem.
271,
25059-25062 |
| 2. | McLennan, A. G. (1999) Int. J. Mol. Med. 4, 79-89[Medline] [Order article via Infotrieve] |
| 3. | Abdelghany, H. M., Gasmi, L., Cartwright, J. L., Bailey, S., Rafferty, J. B., and McLennan, A. G. (2001) Biochim. Biophys. Acta 1550, 27-36[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Guranowski, A. (2000) Pharmacol. Ther. 87, 117-139[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Safrany, S. T.,
Ingram, S. W.,
Cartwright, J. L.,
Falck, J. R.,
McLennan, A. G.,
Barnes, L. D.,
and Shears, S. B.
(1999)
J. Biol. Chem.
274,
21735-21740 |
| 6. | Safrany, S. T., Caffrey, J. J., Yang, X. N., Bembenek, M. E., Moyer, M. B., Burkhart, W. A., and Shears, S. B. (1998) EMBO J. 17, 6599-6607[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Caffrey, J. J.,
Safrany, S. T.,
Yang, X. N.,
and Shears, S. B.
(2000)
J. Biol. Chem.
275,
12730-12736 |
| 8. | Caffrey, J. J., and Shears, S. B. (2001) Gene 269, 53-60[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Hidaka, K.,
Caffrey, J. J.,
Hua, L.,
Zhang, T.,
Falck, J. R.,
Nickel, G. C.,
Carrel, L.,
Barnes, L. D.,
and Shears, S. B.
(2002)
J. Biol. Chem.
277,
32730-32738 |
| 10. | Leslie, N. R., McLennan, A. G., and Safrany, S. T. (2002) BMC Biochem. 3, 20[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Cartwright, J. L.,
and McLennan, A. G.
(1999)
J. Biol. Chem.
274,
8604-8610 |
| 12. | Ingram, S. W., Stratemann, S. A., and Barnes, L. D. (1999) Biochemistry 38, 3649-3655[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Cartwright, J. L.,
Safrany, S. T.,
Dixon, L. K.,
Darzynkiewicz, E.,
Stepinski, J.,
Burke, R.,
and McLennan, A. G.
(2002)
J. Virol.
76,
1415-1421 |
| 14. |
Ye, W. L.,
Ali, N.,
Bembenek, M. E.,
Shears, S. B.,
and Lafer, E. M.
(1995)
J. Biol. Chem.
270,
1564-1568 |
| 15. |
Morrison, B. H.,
Bauer, J. A.,
Kalvakolanu, D. J.,
and Lindner, D. J.
(2001)
J. Biol. Chem.
276,
24965-24970 |
| 16. | Hanakahi, L. A., Bartlet-Jones, M., Chappell, C., Pappin, D., and West, S. C. (2000) Cell 102, 721-729[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Dubois, E.,
Scherens, B.,
Vierendeels, F., Ho, M. M.,
Messenguy, F.,
and Shears, S. B.
(2002)
J. Biol. Chem.
277,
23755-23763 |
| 18. | Bagnara, A. S., Letter, A. A., and Henderson, J. F. (1974) Biochim. Biophys. Acta 374, 259-270[Medline] [Order article via Infotrieve] |
| 19. |
Holmes, E. W.,
Wyngaarden, J. B.,
and Kelley, W. N.
(1973)
J. Biol. Chem.
248,
6035-6040 |
| 20. |
Becker, M. A.,
and Kim, M.
(1987)
J. Biol. Chem.
262,
14531-14537 |
| 21. | Becker, M. A. (2001) Prog. Nucleic Acid Res. Mol. Biol. 69, 115-148[Medline] [Order article via Infotrieve] |
| 22. |
Voll, M. J.,
Appella, E.,
and Martin, R. G.
(1967)
J. Biol. Chem.
242,
1760-1767 |
| 23. |
Alifano, P.,
Fani, R.,
Lio, P.,
Lazcano, A.,
Bazzicalupo, M.,
Carlomagno, M. S.,
and Bruni, C. B.
(1996)
Microbiol. Rev.
60,
44-69 |
| 24. | Hütter, R., Niederberger, P., and DeMoss, J. A. (1986) Annu. Rev. Microbiol. 40, 55-77[Medline] [Order article via Infotrieve] |
| 25. |
Hove-Jensen, B.
(1988)
J. Bacteriol.
170,
1148-1152 |
| 26. |
Kawaguchi, T.,
Veech, R. L.,
and Uyeda, K.
(2001)
J. Biol. Chem.
276,
28554-28561 |
| 27. | Sawada, M., Mitsui, Y., Sugiya, H., and Furuyama, S. (2000) Int. J. Biochem. Cell Biol. 32, 447-454[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Ogushi, S.,
Lawson, J. W. R.,
Dobson, G. P.,
Veech, R. L.,
and Uyeda, K.
(1990)
J. Biol. Chem.
265,
10943-10949 |
| 29. | AbdelRaheim, S. R., Cartwright, J. L., Gasmi, L., and McLennan, A. G. (2001) Arch. Biochem. Biophys. 388, 18-24[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Gasmi, L., Cartwright, J. L., and McLennan, A. G. (1999) Biochem. J. 344, 331-337[Medline] [Order article via Infotrieve] |
| 31. | Lin, S. R., Gasmi, L., Xie, Y., Ying, K., Gu, S. H., Wang, Z., Jin, H., Chao, Y. Q., Wu, C. Q., Zhou, Z. X., Tang, R., Mao, Y. M., and McLennan, A. G. (2002) Biochim. Biophys. Acta 1594, 127-135[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Gasmi, L., and McLennan, A. G. (2001) Biochem. J. 357, 33-38[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Ames, B. N. (1966) Methods Enzymol. 8, 115-118 |
| 34. |
Webb, M. R.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4884-4887 |
| 35. | Canales, J., Pinto, R. M., Costas, M. J., Hernández, M. T., Miró, A., Bernet, D., Fernández, A., and Cameselle, J. C. (1995) Biochim. Biophys. Acta 1246, 167-177[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Peterson, G. L. (1983) Methods Enzymol. 91, 95-119[Medline] [Order article via Infotrieve] |
| 37. | Dennis, A. L., Puskas, M., Stasaitis, S., and Sandwick, R. K. (2000) J. Inorg. Biochem. 81, 73-80[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Trembacz, H., and Jezewska, M. M. (1990) Biochem. J. 271, 621-625[Medline] [Order article via Infotrieve] |
| 39. | Bailey, S., Sedelnikova, S. E., Blackburn, G. M., Abdelghany, H. M., Baker, P. J., McLennan, A. G., and Rafferty, J. B. (2002) Structure 10, 589-600[Medline] [Order article via Infotrieve] |
| 40. |
Petersen, C.
(1999)
J. Biol. Chem.
274,
5348-5356 |
| 41. |
Stuer-Lauridsen, B.,
and Nygaard, P.
(1998)
J. Bacteriol.
180,
457-463 |
| 42. | Hisata, T. (1975) Anal. Biochem. 68, 448-457[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | May, S. R., and Krooth, R. S. (1976) Anal. Biochem. 75, 389-401[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Peters, G. J., and Veerkamp, J. H. (1979) Int. J. Biochem. 10, 885-888[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Traut, T. W. (1994) Mol. Cell. Biochem. 140, 1-22[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Garrison, P. N., and Barnes, L. D. (1992) in Ap4A and Other Dinucleoside Polyphosphates (McLennan, A. G., ed) , pp. 29-61, CRC Press, Boca Raton, Fl |
| 47. |
Menniti, F. S.,
Miller, R. N.,
Putney, J. W.,
and Shears, S. B.
(1993)
J. Biol. Chem.
268,
3850-3856 |
| 48. | Jankowski, J., Potthoff, W., vanderGiet, M., Tepel, M., Zidek, W., and Schlüter, H. (1999) Anal. Biochem. 269, 72-78[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Tax, W. J., and Veerkamp, J. H. (1978) Comp. Biochem. Physiol. B 59, 219-222[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Fox, I. H., and Marchant, P. J. (1974) Can. J. Biochem. 52, 1162-1166[Medline] [Order article via Infotrieve] |
| 51. | Guranowski, A., Brown, P., Ashton, P. A., and Blackburn, G. M. (1994) Biochemistry 33, 235-240[CrossRef][Medline] [Order article via Infotrieve] |
| 52. | Ingram, S. W., Safrany, S.T., and Barnes, L. D., (2002) Biochem. J., in press |
This article has been cited by other articles:
![]() |
J. D. Swarbrick, S. Buyya, D. Gunawardana, K. R. Gayler, A. G. McLennan, and P. R. Gooley Structure and Substrate-binding Mechanism of Human Ap4A Hydrolase J. Biol. Chem., March 4, 2005; 280(9): 8471 - 8481. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwai, S. Kuramitsu, and R. Masui The Nudix Hydrolase Ndx1 from Thermus thermophilus HB8 Is a Diadenosine Hexaphosphate Hydrolase with a Novel Activity J. Biol. Chem., May 21, 2004; 279(21): 21732 - 21739. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Abdelghany, S. Bailey, G. M. Blackburn, J. B. Rafferty, and A. G. McLennan Analysis of the Catalytic and Binding Residues of the Diadenosine Tetraphosphate Pyrophosphohydrolase from Caenorhabditis elegans by Site-directed Mutagenesis J. Biol. Chem., February 7, 2003; 278(7): 4435 - 4439. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||